Rodger Novak - Net Worth and Insider Trading
Rodger Novak Net Worth
The estimated net worth of Rodger Novak is at least $32 Million dollars as of 2024-05-14. Rodger Novak is the President of CRISPR Therapeutics AG and owns about 573,007 shares of CRISPR Therapeutics AG (CRSP) stock worth over $32 Million. Details can be seen in Rodger Novak's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rodger Novak has not made any transactions after 2021-06-30 and currently still holds the listed stock(s).
Transaction Summary of Rodger Novak
Rodger Novak Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rodger Novak owns 1 companies in total, including CRISPR Therapeutics AG (CRSP) .
Click here to see the complete history of Rodger Novak’s form 4 insider trades.
Insider Ownership Summary of Rodger Novak
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2021-06-30 | director & Chief Executive Officer |
Rodger Novak Latest Holdings Summary
Rodger Novak currently owns a total of 1 stock. Rodger Novak owns 573,007 shares of CRISPR Therapeutics AG (CRSP) as of June 30, 2021, with a value of $32 Million.
Latest Holdings of Rodger Novak
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | 2021-06-30 | 573,007 | 55.71 | 31,922,220 |
Holding Weightings of Rodger Novak
Rodger Novak Form 4 Trading Tracker
According to the SEC Form 4 filings, Rodger Novak has made a total of 14 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in CRISPR Therapeutics AG is the sale of 25,000 shares on June 30, 2021, which brought Rodger Novak around $4 Million.
Insider Trading History of Rodger Novak
- 1
Rodger Novak Trading Performance
Rodger Novak Ownership Network
Rodger Novak Owned Company Details
What does CRISPR Therapeutics AG do?
Who are the key executives at CRISPR Therapeutics AG?
Rodger Novak is the director & Chief Executive Officer of CRISPR Therapeutics AG. Other key executives at CRISPR Therapeutics AG include Chief Business Officer Samarth Kulkarni , Chief Financial Officer Raju Prasad , and General Counsel and Secretary James R. Kasinger .
CRISPR Therapeutics AG (CRSP) Insider Trades Summary
Over the past 18 months, Rodger Novak made no insider transaction in CRISPR Therapeutics AG (CRSP). Other recent insider transactions involving CRISPR Therapeutics AG (CRSP) include a net sale of 325,337 shares made by Samarth Kulkarni , a net sale of 5,860 shares made by James R. Kasinger , and a net sale of 3,524 shares made by Raju Prasad .
In summary, during the past 3 months, insiders sold 89,721 shares of CRISPR Therapeutics AG (CRSP) in total and bought 0 shares, with a net sale of 89,721 shares. During the past 18 months, 334,721 shares of CRISPR Therapeutics AG (CRSP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 334,721 shares.
CRISPR Therapeutics AG (CRSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
CRISPR Therapeutics AG Insider Transactions
Rodger Novak Mailing Address
Above is the net worth, insider trading, and ownership report for Rodger Novak. You might contact Rodger Novak via mailing address: C/o Crispr Therapeutics Ag, 200 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
